Systemic hemodynamics and pediatric lung disease: mechanistic links and therapeutic relevance

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Cardiology

Background:

• Bronchopulmonary dysplasia (BPD) significantly impacts infant health and healthcare resources.
• Current BPD treatments primarily target pulmonary aspects, like alveoli, airways, and pulmonary hypertension.
• A subset of infants with severe BPD shows limited response to standard therapies.

Purpose of the Study:

• To explore the role of systemic hemodynamics in severe BPD.
• To identify alternative therapeutic strategies beyond pulmonary artery vasodilatation.
• To investigate the potential of angiotensin-converting enzyme inhibitors for BPD management.

Main Methods:

• Review of existing data on systemic hemodynamics in infants with severe BPD.
• Analysis of pathophysiological links between systemic arterial stiffness, left ventricular dysfunction, and BPD.
• Evaluation of mechanistic pathways including the renin-angiotensin-aldosterone system, inflammation, and oxygen toxicity.

Main Results:

• Systemic hemodynamic alterations, including arterial stiffness and left ventricular dysfunction, are implicated in a subset of severe BPD cases.
• These systemic changes may contribute to BPD pathophysiology through back-pressure effects.
• Heightened renin-angiotensin-aldosterone system activity, inflammation, and oxygen toxicity are potential mechanistic links.

Conclusions:

• Systemic hemodynamic disease is a crucial consideration in severe BPD.
• Angiotensin-converting enzyme inhibition presents a promising alternative to pulmonary artery vasodilatation.
• Targeting systemic afterload reduction may offer a more effective treatment strategy for specific BPD patient groups.